نتایج جستجو برای: rsv process

تعداد نتایج: 1316406  

2014
Shira Hirsh Musa Hindiyeh Liat Kolet Liora Regev Hilda Sherbany Karnit Yaary Ella Mendelson Michal Mandelboim

RSV is the leading cause of lower respiratory-tract infections in infants and therefore demands in-depth epidemiological characterization. We investigated here the distribution of RSV types in Israel between the years 2005-2012. Clinical samples were collected from 11,018 patients hospitalized due to respiratory illnesses and were evaluated for the presence of various respiratory viruses, inclu...

2013
Zhiwu Sun Yanbin Pan Shibo Jiang Lu Lu

Human respiratory syncytial virus (RSV) is the main viral cause of respiratory tract infection in infants as well as some elderly and high-risk adults with chronic pulmonary disease and the severely immunocompromised. So far, no specific anti-RSV therapeutics or effective anti-RSV vaccines have been reported. Only one humanized monoclonal antibody, Palivizumab, has been approved for use in high...

2016
Wenkuan Liu Dehui Chen Weiping Tan Duo Xu Shuyan Qiu Zhiqi Zeng Xiao Li Rong Zhou

Respiratory syncytial virus (RSV) is one of the most important pathogenic infections of children and requires in-depth research worldwide, and especially in developing countries. We used a novel multiplex real-time PCR to test 5483 patients (≤ 14 years old) hospitalized with respiratory illness in Guangzhou, China, over a 3-year period. Of these patients, 729 were positive for RSV-A (51.2%, 373...

Journal: :The Journal of infectious diseases 2008
Joshua J Shinoff Katherine L O'Brien Bhagvanji Thumar Jana B Shaw Raymond Reid Wei Hua Mathuram Santosham Ruth A Karron

Humoral immunity protects against severe respiratory syncytial virus (RSV) disease, but the range and magnitude of antibody responses in RSV-naive children after RSV infection have not been completely defined. We evaluated RSV-neutralizing antibody and immunoglobulin G responses to RSV F and G glycoproteins in 65 RSV-naive Navajo and White Mountain Apache children aged 0-24 months who were hosp...

2014
In Su Cheon Byoung-Shik Shim Sung-Moo Park Youngjoo Choi Ji Eun Jang Dae Im Jung Jae-Ouk Kim Jun Chang Cheol-Heui Yun Man Ki Song

Respiratory syncytial virus (RSV) is a major cause of respiratory tract infection in infants and young children worldwide, but currently no safe and effective vaccine is available. The RSV G glycoprotein (RSVG), a major attachment protein, is an important target for the induction of protective immune responses during RSV infection. However, it has been thought that a CD4+ T cell epitope (a.a. 1...

Journal: :Journal of immunology 2007
Matthew R Olson Steven M Varga

Vaccination of children with a formalin-inactivated (FI) respiratory syncytial virus (RSV) vaccine led to exacerbated disease including pulmonary eosinophilia following a natural RSV infection. Immunization of BALB/c mice with FI-RSV or a recombinant vaccinia virus (vv) expressing the RSV attachment (G) protein (vvG) results in a pulmonary Th2 response and eosinophilia after RSV challenge that ...

Journal: :Journal of virological methods 2007
B Deiman C Schrover C Moore D Westmoreland P van de Wiel

The performance of a sensitive and specific qualitative respiratory syncytial virus (RSV) assay based on NASBA technology and real-time molecular beacon detection is presented. Very low detection limits for both RSV A and RSV B were determined: 95% detection hit-rate of 95 and 47 copies/input in isolation for RSV A and RSV B, respectively. RSV was detected in a wide variety of clinical samples ...

2012
Sol Kim Jun Chang

BACKGROUND Respiratory syncytial virus (RSV) is a major cause of severe lower respiratory tract diseases in infancy and early childhood. Despite its importance as a pathogen, there is no licensed vaccine against RSV yet. The attachment glycoprotein (G) of RSV is a potentially important target for protective antiviral immune responses. Recombinant baculovirus has been recently emerged as a new v...

2013
Kong Michele Maeng Patrick Hong Jeong Szczesniak Rhonda Sorscher Eric Sullender Wayne Clancy John Paul

BACKGROUND Respiratory Syncytial Virus (RSV) infection is a common contributor to pulmonary symptoms in children with cystic fibrosis (CF). Here we examined RSV infection in immortalized bronchial epithelial cells (CFBE41o-) expressing wild-type (wt) or F508del cystic fibrosis transmembrane conductance regulator (CFTR), for monolayer integrity and RSV replication. METHODS CFBE41o- monolayers ...

Journal: :PLoS pathogens 2016
Michael G Currier Sujin Lee Christopher C Stobart Anne L Hotard Remi Villenave Jia Meng Carla D Pretto Michael D Shields Minh Trang Nguyen Sean O Todd Michael H Chi Jason Hammonds Stefanie A Krumm Paul Spearman Richard K Plemper Kaori Sakamoto R Stokes Peebles Ultan F Power Martin L Moore

Respiratory syncytial virus (RSV) is the major cause of viral lower respiratory tract illness in children. In contrast to the RSV prototypic strain A2, clinical isolate RSV 2-20 induces airway mucin expression in mice, a clinically relevant phenotype dependent on the fusion (F) protein of the RSV strain. Epidermal growth factor receptor (EGFR) plays a role in airway mucin expression in other sy...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید